US Stock MarketDetailed Quotes
PPBT Purple Biotech
- 5.420
- +0.250+4.84%
Close Sep 27 16:00 ET
8.49MMarket Cap-423P/E (TTM)
5.541High5.180Low14.51KVolume5.270Open5.170Pre Close77.11KTurnover1.07%Turnover RatioLossP/E (Static)1.57MShares36.00052wk High0.29P/B7.36MFloat Cap5.13052wk Low--Dividend TTM1.36MShs Float1390.000Historical High--Div YieldTTM6.98%Amplitude5.130Historical Low5.314Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Purple Biotech Stock Forum
Purple Biotech Reports Additional Positive Interim Data From Its Randomized Phase 2 Study With Its Lead Oncology Therapeutic Candidate Cm24
Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research
REHOVOT, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced it has been selected for a poster presentation at the American Associati...
Purple Biotech Receives Extension to Regain Compliance With the Nasdaq’s Minimum Bid Price Rule
26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patients administered with CM24+nivolumab+Nal/IRI/5FU/LV vs. standard-of-care(SoC) based on preliminary interim data
Prolongation of 2.1 months in median overall survival ...
I think this one will go to at least a dollar by the end of the month. good potential
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...
No comment yet